Analyst firms · Morgan Stanley · LH
Morgan Stanley LH price target and rating history
Labcorp Holdings Inc. (LH) · Health Care
Morgan Stanley rates Labcorp Holdings Inc. (LH) Overweight with a $300 price target, as of its latest action on Aug 22, 2022. It has published 5 rating actions on LH since August 2021, including 0 upgrades and 0 downgrades.
- Current rating
- Overweight
- Price target
- $300
- Median target, all firms
- Too few
- Actions on LH
- 5
Morgan Stanley price target on LH
Every Morgan Stanley rating on LH
- Aug 22, 2022
- Feb 14, 2022
- Dec 17, 2021
- Oct 29, 2021
- Aug 31, 2021
Questions about Morgan Stanley and LH
- What is Morgan Stanley's price target for LH?
- Morgan Stanley's latest stated price target for Labcorp Holdings Inc. (LH) is $300, from its action on Aug 22, 2022.
- What is Morgan Stanley's rating on LH?
- Morgan Stanley rates LH Overweight, a bullish rating, as of Aug 22, 2022.
- When did Morgan Stanley last change its view on LH?
- On Aug 22, 2022, Morgan Stanley resumes coverage at Overweight, price target $300.
More LH rating histories
All Morgan Stanley ratingsLH news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.